NOACs Added to WHO’s Essential Medicines List: Recommendations for Future Policy Actions

The introduction of non-vitamin K antagonists oral anticoagulants, a class of medicines which includes dabigatran, apixaban, edoxaban and rivaroxaban, has resulted in improvements in the safety and efficacy of non valvular atrial fibrillation treatment for stroke prevention, with significant reducti...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Glob Heart
Hlavní autoři: Di Cesare, Mariachiara, Jarvis, Jordan D., Scarlatescu, Oana, Leng, Xinyi, Zaidel, Ezequiel J., Burrone, Esteban, Eiselé, Jean-Luc, Prabhakaran, Dorairaj, Sliwa, Karen
Médium: Artigo
Jazyk:Inglês
Vydáno: Ubiquity Press 2020
Témata:
Editorial
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7546116/
https://ncbi.nlm.nih.gov/pubmed/33150132
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5334/gh.774
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky